In vitro determination of the efficacy of illicit synthetic cannabinoids at CB 1 receptors-Reference-Cited by-同舟云学术

In vitro determination of the efficacy of illicit synthetic cannabinoids at CB 1 receptors

Published:2019-12 Issue:24 Volume:176 Page:4653-4665
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Sachdev Shivani¹^ORCID,Vemuri Kiran²^ORCID,Banister Samuel D.³⁴^ORCID,Longworth Mitchell⁴,Kassiou Michael⁴^ORCID,Santiago Marina¹^ORCID,Makriyannis Alexandros²^ORCID,Connor Mark¹^ORCID

Affiliation:

1. Department of Biomedical SciencesMacquarie University Sydney NSW Australia

2. Center for Drug Discovery, Department of Pharmaceutical Sciences and Chemical BiologyNortheastern University Boston Massachusetts

3. The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind CentreThe University of Sydney Sydney NSW Australia

4. School of ChemistryThe University of Sydney NSW Australia

Funder

National Health and Medical Research Council

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14829

Reference64 articles.

1. “Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York

2. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors

3. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

4. ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?

5. Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of CB2 Receptors by (−)-Cannabichromene but Not (+)-Cannabichromene;Cannabis and Cannabinoid Research;2024-08-13

2. Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020;Clinical Toxicology;2024-06-02

3. Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA;Drug Testing and Analysis;2024-03-15

4. Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB₂ receptor;Pharmacology Research & Perspectives;2023-11-29

5. Cannabis as a Source of Approved Drugs: A New Look at an Old Problem;Molecules;2023-11-21